ALBERT

All Library Books, journals and Electronic Records Telegrafenberg

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • 52B40  (1)
  • AIDS Vaccines/*immunology  (1)
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Geometriae dedicata 63 (1996), S. 25-43 
    ISSN: 1572-9168
    Keywords: 52B11 ; 52B40 ; 05B35 ; matroid ; oriented matroid ; reorientation class ; d-cube ; d-crosspolytope ; Folkman-Lawrence representation
    Source: Springer Online Journal Archives 1860-2000
    Topics: Mathematics
    Notes: Abstract We prove a conjecture of Las Vergnas in dimensions d≤7: The matroid of the d-dimensional cube C d has a unique reorientation class. This extends a result of Las Vergnas, Roudneff and Salaün in dimension 4. Moreover, we determine the automorphism group G d of the matroid of the d-cube C d for arbitrary dimension d, and we discuss its relation to the Coxeter group of C d . We introduce matroid facets of the matroid of the d-cube in order to evaluate the order of G d . These matroid facets turn out to be arbitrary pairs of parallel subfacets of the cube. We show that the Euclidean automorphism group W d is a proper subgroup of the group G d of all matroid symmetries of the d-cube by describing genuine matroid symmetries for each Euclidean facet. A main theorem asserts that any one of these matroid symmetries together with the Euclidean Coxeter symmetries generate the full automorphism group G d . For the proof of Las Vergnas' conjecture we use essentially these symmetry results together with the fact that the reorientation class of an oriented matroid is determined by the labeled lower rank contractions of the oriented matroid. We also describe the Folkman-Lawrence representation of the vertex figure of the d-cube and a contraction of it. Finally, we apply our method of proof to show a result of Las Vergnas, Roudneff, and Salaün that the matroid of the 24-cell has a unique reorientation class, too.
    Type of Medium: Electronic Resource
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 2
    Publication Date: 2012-10-02
    Description: Developing a vaccine for human immunodeficiency virus (HIV) may be aided by a complete understanding of those rare cases in which some HIV-infected individuals control replication of the virus. Most of these elite controllers express the histocompatibility alleles HLA-B*57 or HLA-B*27 (ref. 3). These alleles remain by far the most robust associations with low concentrations of plasma virus, yet the mechanism of control in these individuals is not entirely clear. Here we vaccinate Indian rhesus macaques that express Mamu-B*08, an animal model for HLA-B*27-mediated elite control, with three Mamu-B*08-restricted CD8(+) T-cell epitopes, and demonstrate that these vaccinated animals control replication of the highly pathogenic clonal simian immunodeficiency virus (SIV) mac239 virus. High frequencies of CD8(+) T cells against these Vif and Nef epitopes in the blood, lymph nodes and colon were associated with viral control. Moreover, the frequency of the CD8(+) T-cell response against the Nef RL10 epitope (Nef amino acids 137-146) correlated significantly with reduced acute phase viraemia. Finally, two of the eight vaccinees lost control of viral replication in the chronic phase, concomitant with escape in all three targeted epitopes, further implicating these three CD8(+) T-cell responses in the control of viral replication. Our findings indicate that narrowly targeted vaccine-induced virus-specific CD8(+) T-cell responses can control replication of the AIDS virus.〈br /〉〈br /〉〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883109/" target="_blank"〉〈img src="https://static.pubmed.gov/portal/portal3rc.fcgi/4089621/img/3977009" border="0"〉〈/a〉   〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883109/" target="_blank"〉This paper as free author manuscript - peer-reviewed and accepted for publication〈/a〉〈br /〉〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Mudd, Philip A -- Martins, Mauricio A -- Ericsen, Adam J -- Tully, Damien C -- Power, Karen A -- Bean, Alex T -- Piaskowski, Shari M -- Duan, Lijie -- Seese, Aaron -- Gladden, Adrianne D -- Weisgrau, Kim L -- Furlott, Jessica R -- Kim, Young-il -- Veloso de Santana, Marlon G -- Rakasz, Eva -- Capuano, Saverio 3rd -- Wilson, Nancy A -- Bonaldo, Myrna C -- Galler, Ricardo -- Allison, David B -- Piatak, Michael Jr -- Haase, Ashley T -- Lifson, Jeffrey D -- Allen, Todd M -- Watkins, David I -- HHSN261200800001E/PHS HHS/ -- P51 OD011106/OD/NIH HHS/ -- R01 AI076114/AI/NIAID NIH HHS/ -- R24 RR015371/RR/NCRR NIH HHS/ -- R37 AI052056/AI/NIAID NIH HHS/ -- RR015371/RR/NCRR NIH HHS/ -- T32 GM008692/GM/NIGMS NIH HHS/ -- England -- Nature. 2012 Nov 1;491(7422):129-33. doi: 10.1038/nature11443. Epub 2012 Sep 30.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin 53711, USA.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/23023123" target="_blank"〉PubMed〈/a〉
    Keywords: AIDS Vaccines/*immunology ; Acquired Immunodeficiency Syndrome/*virology ; Animals ; CD8-Positive T-Lymphocytes/*immunology ; Disease Models, Animal ; Epitopes, T-Lymphocyte/immunology ; Female ; HIV-1/immunology ; HLA-B27 Antigen/immunology ; Humans ; Immunodominant Epitopes/immunology ; Macaca mulatta/immunology/virology ; Male ; SAIDS Vaccines/*immunology ; Simian Acquired Immunodeficiency Syndrome/immunology/*prevention & ; control/virology ; Simian Immunodeficiency Virus/growth & development/*immunology/pathogenicity ; Viral Load ; Viremia/immunology/prevention & control ; Virus Replication/*immunology
    Print ISSN: 0028-0836
    Electronic ISSN: 1476-4687
    Topics: Biology , Chemistry and Pharmacology , Medicine , Natural Sciences in General , Physics
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...